|
|
Close monitoring of individuals diagnosed with chronic hepatitis B is critical to facilitate the successful management of the disease. Patient monitoring typically includes serology — hepatitis B "e" antigen (HBeAg), ALT levels and HBV DNA — and liver biopsy. Treatment may be recommended for patients with elevated ALT levels, active viral replication and biopsy results showing liver injury.
|
|
 |